Global Rare Neurodegenerative Disease Treatment Market Report By Indication (Multiple Sclerosis (MS), Alzheimer’s Disease, Parkinson's Disease, Acute Migraine, Autism, Narcolepsy, Amyotrophic Lateral Sclerosis (ALS), Attention Deficit Hyperactivity Disorder (ADHD), Spinal Muscular Atrophy, Tourette Syndrome, Huntington's Disease, Others), By Drug Class (Neurotransmitter Agents, Neuroprotective Agents, Biologics, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Rare Neurodegenerative Disease Treatment Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11215028

May 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Rare Neurodegenerative Disease Treatment Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Neurodegenerative diseases mainly refer to gradual damage to nerve cells in different parts of the human body. These disorders, including Alzheimer’s disease, ADHD, and ALS, Parkinson’s disease, can lose memory and cognitive control. Though cures for such conditions are very narrow, the pharmaceutical sector has launched several treatment offerings to minimize the symptoms of neurodegenerative diseases over the years.

Market Dynamics

The rise in prevalence and increase in demand for newer drugs to treat rare neurological disorders has led to an increase in research & development efforts followed by introducing innovative neurological disorder drugs. In addition, an increase in demand for neurological disorder drugs for the treatment of Alzheimer’s disease and Parkinson’s disease and a rise in competition between major players are likely to boost the growth of the market. However, the cost of neurological disorder treatment is considerably high, owing to the large quantity of antiepileptic, anticholinergic, and hypnotic & sedatives required. This is likely to impede the global rare neurodegenerative disease treatment market.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of rare neurodegenerative disease treatment. The growth and trends of rare neurodegenerative disease treatment industry provide a holistic approach to this study.

Market Segmentation

This section of the rare neurodegenerative disease treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

Multiple Sclerosis (MS)
Alzheimer’s Disease
Parkinson's Disease
Acute Migraine
Autism
Narcolepsy
Amyotrophic Lateral Sclerosis (ALS)
Attention Deficit Hyperactivity Disorder (ADHD)
Spinal Muscular Atrophy
Tourette Syndrome
Huntington's Disease
Others

By Drug Class

Neurotransmitter Agents
Neuroprotective Agents
Biologics
Others

By Distribution Channel

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Rare Neurodegenerative Disease Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Rare Neurodegenerative Disease Treatment Market Share by Region (Representative Graph)

Know more about this report: Download free sample

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the rare neurodegenerative disease treatment market include Allergan Plc, Bayer AG, F.Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology

2. EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot

3. RARE NEURODEGENERATIVE DISEASE TREATMENT – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Indication
3.7.2 By Drug Class
3.7.3 By Distribution Channel
3.7.4 By Region

4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend

5. IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6. GLOBAL RARE NEURODEGENERATIVE DISEASE TREATMENT MARKET ANALYSIS BY INDICATION
6.1 Overview by Indication
6.2 Historical and Forecast Data
6.3 Analysis by Indication
6.4 Multiple Sclerosis (MS) Market by Regions
6.5 Alzheimer’s Disease Market by Regions
6.6 Parkinson's Disease Market by Regions
6.7 Acute Migraine Market by Regions
6.8 Autism Market by Regions
6.9 Narcolepsy Market by Regions
6.10. Amyotrophic Lateral Sclerosis (ALS) Market by Regions
6.11 Attention Deficit Hyperactivity Disorder (ADHD) Market by Regions
6.12 Spinal Muscular Atrophy Market by Regions
6.13 Tourette Syndrome Market by Regions
6.14 Huntington's Disease Market by Regions

7. GLOBAL RARE NEURODEGENERATIVE DISEASE TREATMENT MARKET ANALYSIS BY DRUG CLASS
7.1 Overview by Drug Class
7.2 Historical and Forecast Data
7.3 Analysis by Drug Class
7.4 Neurotransmitter Agents Market by Regions
7.5 Neuroprotective Agents Market by Regions
7.6 Biologics Market by Regions
7.7 Others Market by Regions

8. GLOBAL RARE NEURODEGENERATIVE DISEASE TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
8.1 Overview by Distribution Channel
8.2 Historical and Forecast Data
8.3 Analysis by Distribution Channel
8.4 Hospital Pharmacies Market by Regions
8.5 Online Pharmacies Market by Regions
8.6 Retail Pharmacies Market by Regions

9. GLOBAL RARE NEURODEGENERATIVE DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America
9.3.1. Overview, Historic and Forecast Data
9.3.2. North America By Segment
9.3.3. North America By Country
9.3.4. United State
9.3.5. Canada
9.3.6. Mexico
9.4. Europe
9.4.1. Overview, Historic and Forecast Data
9.4.2. Europe by Segment
9.4.3. Europe by Country
9.4.4. United Kingdom
9.4.5. France
9.4.6. Germany
9.4.7. Italy
9.4.8. Russia
9.4.9. Rest Of Europe
9.5. Asia Pacific
9.5.1. Overview, Historic and Forecast Data
9.5.2. Asia Pacific by Segment
9.5.3. Asia Pacific by Country
9.5.4. China
9.5.5. India
9.5.6. Japan
9.5.7. South Korea
9.5.8. Australia
9.5.9. Rest Of Asia Pacific
9.6. Latin America
9.6.1. Overview, Historic and Forecast Data
9.6.2. Latin America by Segment
9.6.3. Latin America by Country
9.6.4. Brazil
9.6.5. Argentina
9.6.6. Peru
9.6.7. Chile
9.6.8. Rest of Latin America
9.7. Middle East & Africa
9.7.1. Overview, Historic and Forecast Data
9.7.2. Middle East & Africa by Segment
9.7.3. Middle East & Africa by Country
9.7.4. Saudi Arabia
9.7.5. UAE
9.7.6. Israel
9.7.7. South Africa
9.7.8. Rest Of Middle East And Africa

10. COMPETITIVE LANDSCAPE OF THE RARE NEURODEGENERATIVE DISEASE TREATMENT COMPANIES
10.1. Rare Neurodegenerative Disease Treatment Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF RARE NEURODEGENERATIVE DISEASE TREATMENT INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Allergan Plc
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products
11.3.4. Recent Developments
11.4. Bayer AG
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products
11.4.4. Recent Developments
11.5. F.Hoffmann-La Roche Ltd.
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products
11.5.4. Recent Developments
11.6. GlaxoSmithKline plc
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products
11.6.4. Recent Developments
11.7. Johnson & Johnson
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products
11.7.4. Recent Developments
11.8. Merck KGaA
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products
11.8.4. Recent Developments
11.9. Novartis AG
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Recent Developments
11.10. Pfizer Inc.
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Recent Developments
11.11. Sanofi
11.11.1. Company Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Recent Developments
11.12. Teva Pharmaceutical Industries Ltd.
11.12.1. Company Overview
11.12.2. Financials
11.12.3. Products
11.12.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Rare Neurodegenerative Disease Treatment Report
Market Research Process
Market Research Methodology
Global Rare Neurodegenerative Disease Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Indication
Market Attractiveness Analysis by Drug Class
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Indication (USD MN)
Multiple Sclerosis (MS) Market by Geography (USD MN)
Alzheimer’s Disease Market by Geography (USD MN)
Parkinson's Disease Market by Geography (USD MN)
Acute Migraine Market by Geography (USD MN)
Autism Market by Geography (USD MN)
Narcolepsy Market by Geography (USD MN)
Amyotrophic Lateral Sclerosis (ALS) Market by Geography (USD MN)
Attention Deficit Hyperactivity Disorder (ADHD) Market by Geography (USD MN)
Spinal Muscular Atrophy Market by Geography (USD MN)
Tourette Syndrome Market by Geography (USD MN)
Huntington's Disease Market by Geography (USD MN)
Global Market Analysis by Drug Class (USD MN)
Neurotransmitter Agents Market by Geography (USD MN)
Neuroprotective Agents Market by Geography (USD MN)
Biologics Market by Geography (USD MN)
Others Market by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospital Pharmacies Market by Geography (USD MN)
Online Pharmacies Market by Geography (USD MN)
Retail Pharmacies Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "